Derma Sciences Company Profile (NASDAQ:DSCI)

About Derma Sciences

Derma Sciences logoDerma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company's advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company's traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: DSCI
  • CUSIP: 24982750
Key Metrics:
  • Previous Close: $7.00
  • 50 Day Moving Average: $6.72
  • 200 Day Moving Average: $5.25
  • 52-Week Range: $2.92 - $7.05
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -63.64
  • P/E Growth: 0.00
  • Market Cap: $197.88M
  • Outstanding Shares: 28,269,000
  • Beta: 1.03
Profitability:
  • Net Margins: -12.32%
  • Return on Equity: -4.09%
  • Return on Assets: -3.22%
Debt:
  • Current Ratio: 1.29%
  • Quick Ratio: 1.02%
Additional Links:
Companies Related to Derma Sciences:

Analyst Ratings

Consensus Ratings for Derma Sciences (NASDAQ:DSCI) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Derma Sciences (NASDAQ:DSCI)
Show:
DateFirmActionRatingPrice TargetDetails
1/18/2017Roth CapitalDowngradeBuy -> NeutralView Rating Details
1/9/2016Oppenheimer Holdings, Inc.Reiterated RatingBuyView Rating Details
1/7/2016Canaccord GenuityDowngradeBuy -> Hold$4.00View Rating Details
11/16/2015Piper Jaffray CompaniesLower Price TargetNeutral$6.00 -> $4.00View Rating Details
(Data available from 2/23/2015 forward)

Earnings

Earnings History for Derma Sciences (NASDAQ:DSCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/14/2017        
11/10/2016Q316($0.04)($0.05)$23.90 million$21.80 millionViewListenView Earnings Details
5/11/2016Q116($0.13)($0.07)$20.60 million$20.20 millionViewListenView Earnings Details
3/16/2016Q415($0.39)($0.38)$20.21 million$20.30 millionViewListenView Earnings Details
11/9/2015Q315($0.43)($0.35)$22.31 million$22.20 millionViewListenView Earnings Details
8/10/2015Q215($0.43)($0.36)$21.66 million$22.60 millionViewListenView Earnings Details
5/11/2015Q115($0.46)($0.42)$19.89 million$19.50 millionViewListenView Earnings Details
3/12/2015Q414($0.45)($0.37)$22.90 million$22.90 millionViewListenView Earnings Details
11/10/2014Q314($0.43)($0.45)$21.90 million$20.20 millionViewN/AView Earnings Details
8/7/2014Q2($0.46)($0.34)ViewListenView Earnings Details
5/8/2014Q1($0.32)($0.46)$19.79 million$19.80 millionViewListenView Earnings Details
3/14/2014Q4($0.36)($0.31)$21.26 million$20.70 millionViewListenView Earnings Details
11/13/2013Q3($0.44)($0.29)$21.96 million$22.10 millionViewListenView Earnings Details
8/12/2013Q2 2013($0.45)($0.43)$19.95 million$18.10 millionViewListenView Earnings Details
5/16/2013Q1 2013($0.37)($0.38)$19.00 million$18.80 millionViewListenView Earnings Details
11/12/2012Q312($0.37)($0.24)$19.00 million$19.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Derma Sciences (NASDAQ:DSCI)
Current Year EPS Consensus Estimate: $-0.10 EPS
Next Year EPS Consensus Estimate: $-0.11 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.13)($0.13)($0.13)
Q2 20161($0.08)($0.08)($0.08)
Q3 20161($0.04)($0.04)($0.04)
Q4 20161($0.04)($0.04)($0.04)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Derma Sciences (NASDAQ:DSCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Derma Sciences (NASDAQ:DSCI)
Insider Ownership Percentage: 9.94%
Institutional Ownership Percentage: 58.89%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/18/2015Srini ConjeevaramDirectorBuy1,100$6.50$7,150.00View SEC Filing  
8/14/2015Samuel E NavarroDirectorBuy10,000$6.51$65,100.00View SEC Filing  
8/13/2015Bruce F WessonDirectorBuy10,000$6.58$65,800.00View SEC Filing  
8/13/2015Edward J QuiltyCEOBuy15,000$6.65$99,750.00View SEC Filing  
8/13/2015Robert C ColeInsiderBuy5,000$6.73$33,650.00View SEC Filing  
6/12/2015Brett HewlettDirectorSell12,000$7.17$86,040.00View SEC Filing  
12/15/2014Srini ConjeevaramDirectorSell12,500$8.49$106,125.00View SEC Filing  
12/4/2014C Richard StaffordDirectorSell6,075$8.59$52,184.25View SEC Filing  
11/25/2014C Richard StaffordDirectorSell1,775$8.26$14,661.50View SEC Filing  
11/18/2014C Richard StaffordDirectorSell3,250$8.59$27,917.50View SEC Filing  
11/17/2014C Richard StaffordDirectorSell1,800$8.50$15,300.00View SEC Filing  
11/14/2014C Richard StaffordDirectorSell5,073$8.48$43,019.04View SEC Filing  
9/16/2014Barry WolfensonInsiderBuy3,750$7.99$29,962.50View SEC Filing  
5/19/2014Barry WolfensonInsiderBuy11,250$8.79$98,887.50View SEC Filing  
5/16/2014Edward QuiltyCEOBuy10,000$8.70$87,000.00View SEC Filing  
1/10/2014Ra Capital Management, LlcInsiderSell300,000$11.83$3,549,000.00View SEC Filing  
9/3/2013C Richard StaffordDirectorSell15,000$14.06$210,900.00View SEC Filing  
9/3/2013John YetterCFOSell12,100$14.16$171,336.00View SEC Filing  
5/30/2013William C MartinMajor ShareholderSell95,568$13.68$1,307,370.24View SEC Filing  
4/29/2013Ra Capital Management, LlcMajor ShareholderBuy3,945$11.40$44,973.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Derma Sciences (NASDAQ:DSCI)
DateHeadline
investornewswire.com logoEPS Projection Of Derma Sciences, Inc. (NASDAQ:DSCI) At $-0.04 - Investor Newswire (NASDAQ:DSCI)
www.investornewswire.com - February 22 at 6:44 AM
News IconAnalysts Peer Into Their Crystal Balls For Derma Sciences, Inc. (NASDAQ:DSCI): Where Is It headed? - Winfield Review (NASDAQ:DSCI)
winfieldreview.com - February 22 at 6:44 AM
4-traders.com logoINTEGRA LIFESCIENCES HOLDINGS CORP : Financial Statements and Exhibits (form 8-K) (NASDAQ:DSCI)
www.4-traders.com - February 17 at 7:00 PM
News IconLawsuit filed for Investors in shares Derma Sciences Inc (NASDAQ:DSCI) in effort to Halt the Takeover (NASDAQ:DSCI)
www.groundreport.com - February 13 at 10:34 PM
investornewswire.com logoSentiments And Ratings Alert: Derma Sciences, Inc. (NASDAQ:DSCI) - Investor Newswire (NASDAQ:DSCI)
www.investornewswire.com - February 13 at 6:50 AM
News IconDerma Sciences Inc (DSCI) Shareholder News: Lawsuit Against Buyout by LifeSciences Holdings Corporation - Satellite PR News (press release) (NASDAQ:DSCI)
www.satprnews.com - February 9 at 10:24 PM
News IconDerma Sciences Inc (DSCI) Shareholder News: Lawsuit Against Buyout by LifeSciences Holdings Corporation (NASDAQ:DSCI)
www.ssuchronicle.com - February 8 at 5:17 PM
News IconWhat’s Derma Sciences Inc (DSCI) Upside After Achieving 52-Week High? (NASDAQ:DSCI)
randolphguide.com - February 6 at 4:52 PM
News IconStreet Target Update on Derma Sciences, Inc. (NASDAQ:DSCI) - Aiken Advocate (NASDAQ:DSCI)
aikenadvocate.com - February 5 at 4:43 PM
News IconBroker Changes For Derma Sciences, Inc. (DSCI) - NewsDen (NASDAQ:DSCI)
newsden.net - February 4 at 3:13 AM
News IconChart Level Analysis on Shares of Derma Sciences Inc. (DSCI) - Sherwood Daily (NASDAQ:DSCI)
sherwooddaily.com - February 3 at 5:10 PM
News IconChecking Indicator Levels for Derma Sciences Inc. (DSCI) - Sherwood Daily (NASDAQ:DSCI)
sherwooddaily.com - February 1 at 10:23 PM
News IconDerma Sciences Inc (NASDAQ:DSCI) Investor Alert: Investigation over Buyout by LifeSciences Holdings Corporation (NASDAQ:DSCI)
www.groundreport.com - January 30 at 5:43 PM
businesswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is ... (NASDAQ:DSCI)
www.businesswire.com - January 27 at 6:27 PM
globenewswire.com logoIntegra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc. - GlobeNewswire (press release) (NASDAQ:DSCI)
globenewswire.com - January 26 at 6:05 PM
News IconEarnings in Full Force, Analysts Take Aim at Derma Sciences, Inc. (NASDAQ:DSCI) - Wall Street Beacon (NASDAQ:DSCI)
wsbeacon.com - January 25 at 11:03 PM
finance.yahoo.com logoIntegra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc. (NASDAQ:DSCI)
finance.yahoo.com - January 25 at 6:00 PM
finance.yahoo.com logoIntegra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc. (NASDAQ:DSCI)
finance.yahoo.com - January 25 at 6:00 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:DSCI)
biz.yahoo.com - January 25 at 6:00 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:DSCI)
biz.yahoo.com - January 25 at 6:00 PM
News IconUpdate on Valuation Formula's For Derma Sciences, Inc. (NASDAQ:DSCI) - The Tribune (NASDAQ:DSCI)
lakecitytribune.com - January 24 at 3:14 AM
4-traders.com logoDerma Sciences Inc : Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Derma Sciences, Inc. - DSCI (NASDAQ:DSCI)
www.4-traders.com - January 21 at 4:47 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Derma Sciences, Inc. - DSCI (NASDAQ:DSCI)
finance.yahoo.com - January 20 at 11:04 PM
News IconTechnical Watch on These Shares: Derma Sciences Inc. (DSCI) - Rives Journal (NASDAQ:DSCI)
rivesjournal.com - January 19 at 11:11 PM
News IconTakeover of Derma Sciences Inc (NASDAQ:DSCI) Under Investigation for Investors - Digital Journal (NASDAQ:DSCI)
www.digitaljournal.com - January 19 at 11:11 PM
4-traders.com logoTakeover of Derma Sciences Inc (NASDAQ:DSCI) Under Investigation for Investors (NASDAQ:DSCI)
www.4-traders.com - January 19 at 6:08 PM
News IconDerma Sciences Inc (DSCI) is Downgraded by ROTH Capital to Neutral - Highland Mirror (NASDAQ:DSCI)
www.highlandmirror.com - January 19 at 3:15 AM
finance.yahoo.com logoDerma Sciences downgraded by ROTH Capital (NASDAQ:DSCI)
finance.yahoo.com - January 18 at 5:10 PM
businesswire.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And ... - Business Wire (press release) (NASDAQ:DSCI)
www.businesswire.com - January 17 at 10:41 PM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Shareholders To Contact The Firm For Additional Information (NASDAQ:DSCI)
finance.yahoo.com - January 17 at 10:41 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statemen (NASDAQ:DSCI)
biz.yahoo.com - January 17 at 5:40 PM
finance.yahoo.com logoHarwood Feffer LLP Announces Investigation of Derma Sciences Inc. (NASDAQ:DSCI)
finance.yahoo.com - January 17 at 5:40 PM
prnewswire.com logoDERMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Derma Sciences, Inc. (DSCI ... - PR Newswire (press release) (NASDAQ:DSCI)
www.prnewswire.com - January 15 at 4:40 PM
streetinsider.com logoIntegra LifeSciences (IART) to Acquire Derma Sciences (DSCI) for $7/Share, or 40% Premium (NASDAQ:DSCI)
www.streetinsider.com - January 13 at 10:36 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Derma Sciences, Inc. -DSCI (NASDAQ:DSCI)
finance.yahoo.com - January 13 at 10:35 PM
News IconMomentum Stock in Focus: Derma Sciences Inc (NASDAQ:DSCI) (NASDAQ:DSCI)
seputarkita.info - January 13 at 5:34 PM
News IconDerma Sciences Inc. (NASDAQ:DSCI) has current Market Capitalization of $196480 (NASDAQ:DSCI)
vouxmagazine.com - January 13 at 5:34 PM
finance.yahoo.com logoDERMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Derma Sciences, Inc. (DSCI) Over the Proposed Sale of the Company to Integra LifeSciences Holdings Corporation (NASDAQ:DSCI)
finance.yahoo.com - January 13 at 5:34 PM
News IconRecommended Momentum 'How' and 'Why': Lockheed Martin (NYSE:LMT), Derma Sciences (NASDAQ:DSCI) - Street Wise Report (press release) (blog) (NASDAQ:DSCI)
streetwisereport.com - January 13 at 3:36 AM
businesswire.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc ... - Business Wire (press release) (NASDAQ:DSCI)
www.businesswire.com - January 12 at 10:35 PM
News IconDerma Sciences, Inc. (NASDAQ:DSCI) shows Price to Sale ratio of 1.59 - The Newburgh Press (NASDAQ:DSCI)
newburghpress.com - January 12 at 10:35 PM
News IconStock Vaulting to Uncharted Territory: Derma Sciences, Inc. (NASDAQ:DSCI) - Wall Street Beacon (NASDAQ:DSCI)
wsbeacon.com - January 12 at 10:35 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Investors To Contact The Firm For Additional Information (NASDAQ:DSCI)
finance.yahoo.com - January 12 at 10:35 PM
investopedia.com logoIntegra Buys Derma Sciences for $204M (IART, DSCI) (NASDAQ:DSCI)
www.investopedia.com - January 12 at 5:15 PM
finance.yahoo.com logoBlog Coverage Integra Set to Acquire Derma Sciences; Announced Outlook 2017 (NASDAQ:DSCI)
finance.yahoo.com - January 12 at 5:15 PM
finance.yahoo.com logoCompany News for January 12, 2017 (NASDAQ:DSCI)
finance.yahoo.com - January 12 at 5:15 PM
finance.yahoo.com logoDERMA SCIENCES, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Integra LifeSciences Holdings Corporation May be Unfair to Shareholders (NASDAQ:DSCI)
finance.yahoo.com - January 12 at 5:15 PM
investopedia.com logoIntegra LifeSciences Buys Derma Sciences for $204M (NASDAQ:DSCI)
www.investopedia.com - January 12 at 5:15 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders (NASDAQ:DSCI)
finance.yahoo.com - January 12 at 5:15 PM
nasdaq.com logoIntegra LifeSciences To Buy Derma Sciences For $7.00/shr In Cash (NASDAQ:DSCI)
www.nasdaq.com - January 11 at 10:22 PM

Social

What is Derma Sciences' stock symbol?

Derma Sciences trades on the NASDAQ under the ticker symbol "DSCI."

When will Derma Sciences announce their earnings?

Derma Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, March, 14th 2017.

Who owns Derma Sciences stock?

Derma Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Franklin Resources Inc. (9.44%), Broadfin Capital LLC (9.06%), Renaissance Technologies LLC (2.23%), Royce & Associates LP (1.94%) and Dimensional Fund Advisors LP (0.26%). Company insiders that own Derma Sciences stock include Brett Hewlett, Bruce F Wesson, Edward J Quilty, Robert C Cole, Samuel E Navarro and Srini Conjeevaram.

Who sold Derma Sciences stock? Who is selling Derma Sciences stock?

Derma Sciences' stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Renaissance Technologies LLC and Dimensional Fund Advisors LP.

Who bought Derma Sciences stock? Who is buying Derma Sciences stock?

Derma Sciences' stock was purchased by a variety of institutional investors in the last quarter, including Royce & Associates LP. Company insiders that have bought Derma Sciences stock in the last two years include Bruce F Wesson, Edward J Quilty, Robert C Cole, Samuel E Navarro and Srini Conjeevaram.

How do I buy Derma Sciences stock?

Shares of Derma Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Derma Sciences stock cost?

One share of Derma Sciences stock can currently be purchased for approximately $7.00.

Derma Sciences (NASDAQ:DSCI) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Derma Sciences (NASDAQ:DSCI)

Earnings History Chart

Earnings by Quarter for Derma Sciences (NASDAQ:DSCI)

Dividend History Chart

Dividend Payments by Quarter for Derma Sciences (NASDAQ:DSCI)

Last Updated on 2/23/2017 by MarketBeat.com Staff